1. Home
  2. UAMY vs MRVI Comparison

UAMY vs MRVI Comparison

Compare UAMY & MRVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • UAMY
  • MRVI
  • Stock Information
  • Founded
  • UAMY 1968
  • MRVI 2014
  • Country
  • UAMY United States
  • MRVI United States
  • Employees
  • UAMY N/A
  • MRVI N/A
  • Industry
  • UAMY Metal Fabrications
  • MRVI Biotechnology: Pharmaceutical Preparations
  • Sector
  • UAMY Industrials
  • MRVI Health Care
  • Exchange
  • UAMY Nasdaq
  • MRVI Nasdaq
  • Market Cap
  • UAMY 316.8M
  • MRVI 312.4M
  • IPO Year
  • UAMY N/A
  • MRVI 2020
  • Fundamental
  • Price
  • UAMY $3.35
  • MRVI $2.69
  • Analyst Decision
  • UAMY Strong Buy
  • MRVI Hold
  • Analyst Count
  • UAMY 4
  • MRVI 10
  • Target Price
  • UAMY $3.38
  • MRVI $6.84
  • AVG Volume (30 Days)
  • UAMY 7.3M
  • MRVI 1.9M
  • Earning Date
  • UAMY 08-08-2025
  • MRVI 08-06-2025
  • Dividend Yield
  • UAMY N/A
  • MRVI N/A
  • EPS Growth
  • UAMY N/A
  • MRVI N/A
  • EPS
  • UAMY N/A
  • MRVI N/A
  • Revenue
  • UAMY $18,865,900.00
  • MRVI $241,856,000.00
  • Revenue This Year
  • UAMY $270.45
  • MRVI N/A
  • Revenue Next Year
  • UAMY $104.06
  • MRVI $10.91
  • P/E Ratio
  • UAMY N/A
  • MRVI N/A
  • Revenue Growth
  • UAMY 97.46
  • MRVI N/A
  • 52 Week Low
  • UAMY $0.31
  • MRVI $1.67
  • 52 Week High
  • UAMY $4.19
  • MRVI $10.03
  • Technical
  • Relative Strength Index (RSI)
  • UAMY 56.29
  • MRVI 58.67
  • Support Level
  • UAMY $3.28
  • MRVI $2.35
  • Resistance Level
  • UAMY $3.82
  • MRVI $2.93
  • Average True Range (ATR)
  • UAMY 0.34
  • MRVI 0.17
  • MACD
  • UAMY 0.07
  • MRVI -0.01
  • Stochastic Oscillator
  • UAMY 58.58
  • MRVI 58.97

About UAMY United States Antimony Corporation

United States Antimony Corp is a fully integrated mining, transportation, milling, smelting, and selling company. It has two operating segments: antimony and zeolite. Its products and services include antimony; silver; gold; zeolite products; and storage, handling, & packaging services. The company's geographical segments are the United States, Canada, and Mexico, of which the vast majority of its revenue comes from the United States.

About MRVI Maravai LifeSciences Holdings Inc.

Maravai LifeSciences Holdings Inc is a life sciences company that provides critical products that drive the development of groundbreaking vaccines, drug therapies, cell and gene therapies, and diagnostics. The group's solutions empower research into human diseases and support the entire biopharmaceutical development process from early discovery to commercialization. Its reportable segments are Nucleic acid production and biologics safety testing. It generates a majority of its revenue from Nucleic Acid Production and focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, and therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.

Share on Social Networks: